ATXS
NASDAQ
$12.58
Astria Therapeutics Inc (ATXS)
Sector:
Healthcare
Industry:
Biotechnology
Market Cap
$710M
EPS 5Y CAGR
+26.37%
FCF 5Y CAGR
+30.14%
Free Cash Flow Yield
-16.95%
Price Chart
Valuation
Market Cap$710M
Profitability
Total Revenue (TTM)$706K
Gross Profit (TTM)$706K
EBITDA-$124M
EPS-$2.20
Financial Health
Free Cash Flow Yield-16.95%
Growth & Risk
EPS 5Y CAGR+26.37%
FCF 5Y CAGR+30.14%
Sharpe Ratio1.01